Howard Colman

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2018-11 cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” in ACTA NEUROPATHOLOGICA
  • 2017-04 Glioma Subclassifications and Their Clinical Significance in NEUROTHERAPEUTICS
  • 2017-02 New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M in CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
  • 2017-02 Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial in JOURNAL OF NEURO-ONCOLOGY
  • 2016-08 Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2016-01 A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study in JOURNAL OF NEURO-ONCOLOGY
  • 2015-12 Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism in STEM CELL RESEARCH & THERAPY
  • 2015-12 DNA copy number analysis of Grade II–III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status in ACTA NEUROPATHOLOGICA COMMUNICATIONS
  • 2015 Glioma Biology and Molecular Markers in CURRENT UNDERSTANDING AND TREATMENT OF GLIOMAS
  • 2013-06 Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation in ONCOGENE
  • 2013-05 IDH1 and IDH2 Mutations in Gliomas in CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
  • 2013-05 Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme in JOURNAL OF NEURO-ONCOLOGY
  • 2012-11 Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme in JOURNAL OF NEURO-ONCOLOGY
  • 2012-05 Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway in JOURNAL OF NEURO-ONCOLOGY
  • 2011-04 Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma in JOURNAL OF NEURO-ONCOLOGY
  • 2011-02 Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments in CURRENT ONCOLOGY REPORTS
  • 2010-11-20 Molecular Pathogenesis in PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
  • 2010-01 Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan in GLYCOCONJUGATE JOURNAL
  • 2010-01 The transcriptional network for mesenchymal transformation of brain tumours in NATURE
  • 2009-09 Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma in JOURNAL OF NEURO-ONCOLOGY
  • 2009-06 Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters in ONCOGENE
  • 2008-10 Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma in JOURNAL OF NEURO-ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Colman", 
        "givenName": "Howard", 
        "id": "sg:person.01261043223.41", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:54", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_618.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    30 TRIPLES      10 PREDICATES      18 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01261043223.41 schema:affiliation N1a0f32c61025461185984130e22ba46e
    9 schema:familyName Colman
    10 schema:givenName Howard
    11 schema:sameAs
    12 schema:sdDatePublished 2019-03-07T14:54
    13 schema:sdLicense
    14 schema:sdPublisher Nbdd6ba9c59d14e0ba0748685bfd2070c
    15 sgo:license sg:explorer/license/
    16 sgo:sdDataset persons
    17 rdf:type schema:Person
    18 N1a0f32c61025461185984130e22ba46e schema:affiliation
    19 sgo:isCurrent true
    20 rdf:type schema:OrganizationRole
    21 Nbdd6ba9c59d14e0ba0748685bfd2070c schema:name Springer Nature - SN SciGraph project
    22 rdf:type schema:Organization
    23 schema:Organization
    24 schema:Organization
    25 schema:Organization
    26 schema:Organization
    27 schema:Organization
    28 schema:Organization
    29 schema:Organization
    30 schema:Organization

    Preview window. Press ESC to close (or click here)